Tarsus Pharmaceuticals akan mengakuisisi Alkeus Pharmaceuticals (TARS:NASDAQ)
· seekingalpha.com
Tarsus (TARS) akan mengakuisisi Alkeus senilai $450 juta di muka ditambah pembayaran berbasis tonggak pencapaian (milestones), menambahkan obat penyakit Stargardt, gildeuretinol.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...